Inactivated vaccine against braxy, enterotoxemia, malignant edema and dysentery

Indications
Indications (high-risk and outbreak herds):

• Braxy
• Enterotoxemia
• Malignant edema
• Clostridial dysentery (lamb dysentery)

Description
An inactivated vaccine formulated from toxigenic strains of Clostridium perfringens types B, C and D, Cl. oedematiens and Cl. septicum.
The antigens are formalin-inactivated and adjuvanted with aluminum hydroxide gel.
The product is intended to prevent acute clostridial infections in sheep, particularly during pasture seasons when risk is highest.

Target Animals:

• Sheep

Immunity and Dosage
Method of use: injections.
From 3 months of age, intramuscularly twice at a 20–30-day interval.
Category 1st dose → 2nd dose:

• Adult sheep 2.0 ml → 3.0 ml.
• Lambs ≤ 6 months 1.0 ml → 1.5 ml.

Immunity develops 10–12 days after the second injection and lasts at least 5 months.